J3M-MC-JZQB

By: Medable Inc.

Study for patients with KRAS G12C-Mutant, Metastatic Non-Small Cell Lung Cancer

Features & Capabilities

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.

User Growth & Download Statistics

App

By:

Downloads:

Version:

5.4.1200.2-prod Last updated: 2026-02-20

Version code:

541200002

Creation date:

2024-07-02

Publisher country:

US

Permissions:

android.permission.ACCESS_COARSE_LOCATION Very high risk
android.permission.ACCESS_FINE_LOCATION Very high risk
android.permission.CAMERA Very high risk
android.permission.RECORD_AUDIO Very high risk
android.permission.ACCESS_BACKGROUND_SERVICE Moderate risk
android.permission.BLUETOOTH_CONNECT Moderate risk
android.permission.ACCESS_WIFI_STATE Low risk
android.permission.FOREGROUND_SERVICE Low risk
android.permission.INTERNET Low risk
android.permission.MODIFY_AUDIO_SETTINGS Low risk

Size:

54.64MB

Email:

su*****@medable.com

URLs:

Full description:

Source:

Google Play Store

Data ingested on:

2026-06-12

Compare stats and ranking:

Ranking

# 1,884,064 ▲ 8,359

For Developers

Monetize with App Pass Boost with Extension Booster

Contact the developer

Chrome-Stats does not own this Android app. Please use these information below to contact the Android app developer.

Developed by:

Medable Inc.

Google Play Store

https://play.google.com/store/apps/details?id=com.medable.lilly.jzqb

Email:

su*****@medable.com

Best J3M-MC-JZQB Alternatives

Here are some Android apps that are similar to J3M-MC-JZQB:

GSK 214760 Patient

HERTHENA-Lung02

GSK BLISSc-ILD 218224 Patient